Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
hCAII-IN-4
Cat. No.:
OB0425LY-177
Appearance:
Solid
Purity:
≥95%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
hCAII-IN-4 is a selective amino acid enzyme inhibitor targeting human carbonic anhydrase II (hCAII) which inhibits β-glucuronidase.
Synonyms:
2816080-18-7; hCAII-IN-4; hCAII-IN4
CAS No.:
2816080-18-7
Compound CID:
164887559
Formula:
C31H23NO9
Formula Weight:
553.52
Specification
Target:
Carbonic anhydrase; β-glucuronidase
Pathway:
Metabolic enzyme/Protease
Storage:
Storage at -20°C.
Applications:
hCAII-IN-4 has a broad potential for application in the regulation of acid-base balance and physiological processes.
